Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
The British Journal of Radiology|September 8, 2022
Synergizing liver systemic treatments with interventional oncology: friend or foe?Raphaël Jost, Nael Al-Shatti, Mario Ghosn, et al.
European Journal of Cancer (Oxford, England : 1990)|November 20, 2022
Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscleSami Antoun, Emilie Lanoy, Samy Ammari, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2023
Profile and outcome of cancer patients enrolled in contemporary phase I trialsEmily Alouani, Anas Gazzah, Sandrine Mercier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2023
Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on ImmunotherapyYounes Belkouchi, Hugues Talbot, Nathalie Lassau, et al.
Nature Reviews. Clinical Oncology|May 5, 2016
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combinationCeline Boutros, Ahmad Tarhini, Emilie Routier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2021
Interventional Radiology for Local Immunotherapy in OncologyLambros Tselikas, Stephane Champiat, Rahul A Sheth, et al.
Clinical Kidney Journal|February 13, 2019
Renal toxicities associated with pembrolizumabHassan Izzedine, Alexis Mathian, Stephane Champiat, et al.
Journal for Immunotherapy of Cancer|March 31, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminologyJarushka Naidoo, Catherine Murphy, Michael B Atkins, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2020
Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancerPatricia Martin-Romano, Samy Ammari, Yolla El-Dakdoukti, et al.
NPJ Precision Oncology|January 13, 2026
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD AndersonJeong Uk Lim, Heather Y Lin, Lei Kang, et al.
Pageof 5